论文部分内容阅读
目的:应用药物经济学成本-效果(CEA)分析医院炮制的四种蜜炙中药的药物经济学意义。方法:选取医院炮制的四种蜜炙中药(黄芪、远志、麻黄、甘草)相关资料,与同期直接从市场采购的上述四种蜜炙中药炮制品进行比较,运用CEA分析二者间的成本-效果比B/C和净现值NPV。结果:医院加工炮制品的B/C及NPV均显著大于直接从市场采购的炮制品,差异均具有统计学意义(P<0.05)。结论:在合理用药、保证疗效的情况下,医院加工炮制品的成本-效果比及净现值更大,更有利于临床使用。医院炮制中药较直接从市场采购的炮制品在药物经济学上更有意义。
OBJECTIVE: To analyze the pharmacoeconomic significance of four honey-cured Chinese herbs concocted by the hospital with the cost-effectiveness (CEA) of pharmacoeconomics. Methods: Four kinds of honey-cured Chinese herbs (Astragalus, Polygala, Ephedra, Licorice) concocted by the hospital were compared with those of the above-mentioned four kinds of honey-cured Chinese herbal medicines purchased directly from the market in the same period. CEA was used to analyze the cost- The effect is better than B / C and NPV. Results: The B / C and NPV of processed products in the hospital were significantly higher than those processed directly from the market, the differences were statistically significant (P <0.05). Conclusion: In the reasonable use of drugs, to ensure the efficacy of the case, the hospital processed products cost-effect ratio and net present value greater, more conducive to clinical use. It is more significant in pharmacoeconomics that processed Chinese medicines purchased by the hospital than those procured directly from the market.